TREATMENT OF PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER WITH AN CDK4/6 INHIBITOR COMBINED WITH ENDOCRINE AGENTS: A REAL-WORLD EXPERIENCE

Kurbacher Christian Martin; Fischer Lotta Ada; Heinrich Georg; Warm Mathias; Schott Alexander; Kurbacher A. Tabea; Kurbacher Jutta Anna; Rudlowski Christian

首页> 外文期刊>The Breast : >TREATMENT OF PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER WITH AN CDK4/6 INHIBITOR COMBINED WITH ENDOCRINE AGENTS: A REAL-WORLD EXPERIENCE

【24h】

TREATMENT OF PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER WITH AN CDK4/6 INHIBITOR COMBINED WITH ENDOCRINE AGENTS: A REAL-WORLD EXPERIENCE

机译：用CDK4 / 6抑制剂与内分泌剂结合内分泌试剂的血液活性阳性患者患有激素受体阳性阳性的前辈患者：真实的世界经验

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Breast :》 |2019年第2期|共2页
作者
Kurbacher Christian Martin; Fischer Lotta Ada; Heinrich Georg; Warm Mathias; Schott Alexander; Kurbacher A. Tabea; Kurbacher Jutta Anna; Rudlowski Christian;
展开▼
作者单位

Gynecol Ctr Bonn Friedenspl Gynecol Gynecol Oncol 1 Bonn Germany;

Municipal Hosp Holweide Breast Ctr Cologne Germany;

Gynecol Oncol Practice Gynecol &

Obstet Furstenwalde Germany;

Municipal Hosp Holweide Breast Ctr Cologne Germany;

Gynecol Ctr Bonn Friedenspl Gynecol Gynecol Oncol 1 Bonn Germany;

Gynecol Ctr Bonn Friedenspl Gynecol Gynecol Oncol 1 Bonn Germany;

Gynecol Ctr Bonn Friedenspl Gynecol Gynecol &

Obstet 2 Bonn Germany;

Evangel Krankenhaus Gynecol &

Obstet Bergisch Gladbach Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类胸部外科学;
关键词

相似文献

外文文献
中文文献
专利

1. TREATMENT OF PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER WITH AN CDK4/6 INHIBITOR COMBINED WITH ENDOCRINE AGENTS: A REAL-WORLD EXPERIENCE [J] . Kurbacher Christian Martin, Fischer Lotta Ada, Heinrich Georg, The Breast : . 2019,第Suppla2期

机译：用CDK4 / 6抑制剂与内分泌剂结合内分泌试剂的血液活性阳性患者患有激素受体阳性阳性的前辈患者：真实的世界经验
2. QT-interval prolongation during the treatment with ribociclib and endocrine agents in patients with hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancer: A real-world experience [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：Qt间隔在激素受体阳性阳性患者中核酸和内分泌试剂治疗期间延长，人体表皮生长因子2阴性转移性乳腺癌：真实的世界经验
3. THE INCIDENCE OF QT INTERVAL PROLONGATION IN PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER TREATED WITH RIBOCICLIB COMBINED WITH ENDOCRINE THERAPY IN A REAL-WORLD SETTING [J] . Kurbacher Christian Martin, Kurbacher A. Tabea, Schott Alexander, The Breast : . 2019,第Suppla2期

机译：用核核苷酸治疗的激素受体阳性，HER2阴性转移性乳腺癌患者QT间隔延长的发病率与真实世界的环境中内分泌治疗
4. ROLE OF ENDOCRINE DISRUPTOR CHEMICALS ON THE TISSUE LEVELS OF AHR AND SEX STEROID RECEPTORS IN PREMENOPAUSAL BREAST CANCER PATIENTS : COMPARISON WITH BENIGN FEMALE TUMOURS [C] . Sepideh Arbabi Bidgoli International Conference on Endocrine Disruptors . 2012

机译：内分泌干扰化学品对前肢乳腺癌患者AHR和性类固醇受体组织水平的作用：与良性女性肿瘤的比较
5. Treatment Interruption and Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients [D] . Mao, Daqin . 2020

机译：激素受体阳性乳腺癌患者中的治疗中断与激素治疗中的中断和停止
6. Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive HER2-negative metastatic breast cancer [O] . Mingxi Lin, Yang Chen, Yizi Jin, 2020

机译：CDK4 / 6抑制剂的比较整体存活加上内分泌治疗与内分泌治疗单独用于激素受体阳性HER2阴性转移性乳腺癌
7. CDK4/6 inhibitors for hormone receptor-positive HER2-negative metastatic breast cancer: does one size fit all? [O] . Palma Fedele, Saverio Cinieri 2019

机译：CDK4 / 6激素受体阳性HER2阴性转移性乳腺癌的抑制剂：一个尺寸适合所有吗？

TREATMENT OF PREMENOPAUSAL PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER WITH AN CDK4/6 INHIBITOR COMBINED WITH ENDOCRINE AGENTS: A REAL-WORLD EXPERIENCE

著录项

相似文献

相关主题

期刊订阅